Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death

被引:35
|
作者
Carroll, Sandra L. [1 ]
Strachan, Patricia H. [1 ]
de Laat, Sonya [1 ]
Schwartz, Lisa [2 ]
Arthur, Heather M. [3 ]
机构
[1] McMaster Univ, Sch Nursing, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Arnold L Johnson Chair Hlth Care Eth, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Michael G DeGroote Endowed Chair Cardiovasc Nursi, Heart & Stroke Fdn Ontario, Sch Nursing, Hamilton, ON L8S 4K1, Canada
基金
加拿大健康研究院;
关键词
cardiovascular; implantable defibrillator; patient decision making; patient values; primary prevention; sudden cardiac death; SURVIVAL;
D O I
10.1111/j.1369-7625.2011.00703.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Patients are offered implantable defibrillators (ICDs) for the prevention of sudden cardiac death (SCD). However, patients' decision-making process (DMP) of whether or not to accept an ICD has not been explored. We asked patients about their decision making when offered an ICD. Design/Setting A grounded theory methodology was employed. Patients were recruited from three ICD centres. Those who received an ICD underwent interviews the first month after implant. Declining patients had interviews at their convenience. In-depth analysis of transcripts was completed. Identified themes were placed along process pathways in a DMP model and tested. Findings Forty-four patients consented to participate (25% women). Thirty-four accepted an ICD and 10 (23%) declined. Ages ranged from 26 to 87 (mean=65; SD=12.5). Participants were retired (65%), had ischaemic heart disease (64%) and some post-secondary education (52%). The DMP was triggered when patient's risk for SCD was communicated. The physician's recommendation and a new awareness SCD risk were motivators to accept the ICD. Patient's decision-making approaches fell along a continuum, from active and engaged to passive and indifferent. Patient's approaches were influenced most by the following: (i) trust; (ii) social influences and (iii) health state. Conclusions Health-care providers need to recognize the DMP pathways in which ICD candidacy and SCD risk are understood. The factors that influence a patient's decision warrant discussion pre-implant. It is imperative that patients comprehend the meaning of ICD candidacy to make an informed decision. Participants did not recall alternatives to receiving ICD therapy.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 50 条
  • [31] Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of sudden death
    Rodenas Alesina, E. Eduardo
    Ribera, A.
    Gimenez, E.
    Oristrell, G.
    Osorio, D.
    Marsal, J. R.
    Garcia-Perez, L.
    Ballesteros, M.
    Belahnech, Y.
    Escalona, R.
    Rivas, N.
    Roca-Luque, I.
    Ferreira-Gonzalez, I.
    Espallargues, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 7 - 8
  • [32] Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death
    Mezu, Ure
    Ch, Iftikhar
    Halder, Indrani
    London, Barry
    Saba, Samir
    EUROPACE, 2012, 14 (03): : 341 - 344
  • [33] Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death
    Auricchio, A.
    Curtis, A. B.
    Mittal, S.
    Pickett, R. A.
    Jacobsen, L.
    Lande, J. D.
    Wilkoff, B. L.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [34] Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Begley, DA
    Mohiddin, SA
    Tripodi, D
    Winkler, JB
    Fananapazir, L
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (09): : 1887 - 1896
  • [35] SURVIVAL OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECIPIENT FOR PRIMARY PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE
    Joncas, S. X.
    Ayala-Paredes, F. A.
    Carrier, N.
    Farand, P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S342 - S342
  • [36] Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death
    Madhavan, Malini
    Waks, Jonathan W.
    Friedman, Paul A.
    Kramer, Daniel B.
    Buxton, Alfred E.
    Noseworthy, Peter A.
    Mehta, Ramila A.
    Hodge, David O.
    Higgins, Angela Y.
    Webster, Tracy L.
    Witt, Chance M.
    Cha, Yong-Mei
    Gersh, Bernard J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (03):
  • [37] Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
    Platonov, Pyotr G.
    Haugaa, Kristina H.
    Bundgaard, Henning
    Svensson, Anneli
    Gilljam, Thomas
    Hansen, Jim
    Madsen, Trine
    Host, Anders Gaarsdal
    Carlson, Jonas
    Lie, Oyvind H.
    Jensen, Morten Kvistholm
    Edvardsen, Thor
    Jensen, Henrik K.
    Svendsen, Jesper H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (07): : 1156 - 1162
  • [38] Implantable cardioverter-defibrillator therapy for primary prevention of sudden cardiac death in patients with Chagas vs ischemic cardiomyopathy
    Guillermo Mora, G.
    Guarnizo, A.
    Cortes, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 246 - 246
  • [39] Should the implantable cardiac defibrillator be used for primary prevention of sudden death? A review of the issues relevant to hospital decision making
    McGregor, M
    Chen, J
    CANADIAN JOURNAL OF CARDIOLOGY, 2004, 20 (12) : 1199 - 1204
  • [40] Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
    Ding, Ligang
    Hua, Wei
    Niu, Hongxia
    Chen, Keping
    Zhang, Shu
    EUROPACE, 2008, 10 (09): : 1034 - 1041